98 related articles for article (PubMed ID: 24616042)
1. Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent.
Ramaswamy V; Remke M; Shih D; Wang X; Northcott PA; Faria CC; Raybaud C; Tabori U; Hawkins C; Rutka J; Taylor MD; Bouffet E
Pediatr Blood Cancer; 2014 Jul; 61(7):1190-4. PubMed ID: 24616042
[TBL] [Abstract][Full Text] [Related]
2. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
3. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
[TBL] [Abstract][Full Text] [Related]
4. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
6. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?
Halperin EC; Friedman HS
Cancer; 1996 Aug; 78(4):874-80. PubMed ID: 8756384
[TBL] [Abstract][Full Text] [Related]
7. [Clinical course and prognosis in medulloblastoma in infants and young children].
Wagner W; Böttcher HD; Korinthenberg R; Schadel A; Schmilowski M
Klin Padiatr; 1983 Mar; 195(2):100-2. PubMed ID: 6855144
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
9. Childhood medulloblastoma in Ontario, 1977-1987: population-based results.
Danjoux CE; Jenkin RD; McLaughlin J; Grimard L; Gaspar LE; Dar AR; Fisher B; Whitton AC; Kraus V; Springer CD
Med Pediatr Oncol; 1996 Jan; 26(1):1-9. PubMed ID: 7494506
[TBL] [Abstract][Full Text] [Related]
10. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.
Halperin EC; Watson DM; George SL
Cancer; 2001 Apr; 91(8):1444-50. PubMed ID: 11301391
[TBL] [Abstract][Full Text] [Related]
11. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
12. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
14. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
15. Surveillance scanning of children with medulloblastoma.
Torres CF; Rebsamen S; Silber JH; Sutton LN; Bilaniuk LT; Zimmerman RA; Goldwein JW; Phillips PC; Lange BJ
N Engl J Med; 1994 Mar; 330(13):892-5. PubMed ID: 8114859
[TBL] [Abstract][Full Text] [Related]
16. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
Liu Y; Zhu Y; Gao L; Xu G; Yi J; Liu X; Li Y
Jpn J Clin Oncol; 2005 Mar; 35(3):111-5. PubMed ID: 15741299
[TBL] [Abstract][Full Text] [Related]
17. Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country.
Amayiri N; Swaidan M; Ibrahimi A; Hirmas N; Musharbash A; Bouffet E; Al-Hussaini M; Ramaswamy V
JCO Glob Oncol; 2021 Sep; 7():1442-1453. PubMed ID: 34609903
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
19. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
20. Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive.
Johnston DL; Keene D; Kostova M; Lafay-Cousin L; Fryer C; Scheinemann K; Carret AS; Fleming A; Percy V; Afzal S; Wilson B; Bowes L; Zelcer S; Mpofu C; Silva M; Larouche V; Brossard J; Strother D; Bouffet E
J Neurooncol; 2015 Sep; 124(2):247-53. PubMed ID: 26024655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]